Who owns GRACELL BIOTECHNOLOGIES INC?
- CUSIP Number: 38406l103
Tip: Access positions for across all investors
Analyze quarterly positions in Gracell Biotechnologies with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Gracell Biotechnologies stock
Who bought or sold GRACELL BIOTECHNOLOGIES INC this quarter?
There are no current stakeholders of Gracell Biotechnologies.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Gracell Biotechnologies?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vivo Capital | Dec 2023 | 9.5M | $96M |
| OrbiMed Advisors | Dec 2023 | 9.3M | $94M |
| Tang Capital Management | Dec 2023 | 2.2M | $22M |
| Sio Capital Management | Sep 2023 | 2.1M | $6.0M |
| Baker Bros. Advisors | Dec 2023 | 2.1M | $21M |
| Pentwater Capital Management | Dec 2023 | 1.5M | $15M |
| TIG Advisors | Dec 2023 | 1.3M | $13M |
| Alpine Associates Management | Dec 2023 | 1.3M | $13M |
| Adage Capital Partners GP | Sep 2023 | 850k | $2.4M |
| Octagon Capital Advisors | Dec 2023 | 597k | $6.0M |
| BlackRock | Sep 2023 | 559k | $1.6M |
| Bank of America Corporation | Dec 2023 | 512k | $5.1M |
| LMR Partners | Dec 2023 | 510k | $3.3M |
| Sphera Funds Management | Dec 2023 | 503k | $5.0M |
| MMCAP International Inc. SPC | Dec 2023 | 451k | $4.5M |
| Hudson Bay Capital Management | Dec 2023 | 267k | $2.7M |
| Marshall Wace | Dec 2023 | 193k | $1.9M |
| Millennium Management | Dec 2023 | 191k | $1.9M |
| CNH Partners | Dec 2023 | 131k | $1.3M |
| UBS Group | Dec 2023 | 126k | $1.3M |
| Weiss Asset Management LP[1 | Dec 2023 | 109k | $1.1M |
| Morgan Stanley | Sep 2023 | 99k | $296k |
| Two Sigma Investments | Dec 2023 | 88k | $880k |
| Verition Fund Management | Sep 2023 | 87k | $250k |
| CSS | Dec 2023 | 73k | $733k |
| Citadel Advisors | Dec 2023 | 65k | $652k |
| Cubist Systematic Strategies | Dec 2023 | 59k | $593k |
| Fifth Lane Capital | Dec 2023 | 58k | $586k |
| Polar Securities | Dec 2023 | 50k | $502k |
| Pathstone Holdings | Dec 2023 | 49k | $494k |
| Geode Capital Management | Sep 2023 | 43k | $125k |
| Exome Asset Management | Dec 2023 | 41k | $411k |
| Tower Research Capital | Sep 2023 | 34k | $99k |
| Two Sigma Advisers | Dec 2023 | 34k | $337k |
| Equitec Proprietary Markets | Dec 2023 | 32k | $323k |
| Gts Securities | Dec 2023 | 25k | $252k |
| Royal Bank of Canada | Dec 2023 | 25k | $251k |
| PenderFund Capital Management | Dec 2023 | 23k | $300k |
| Balyasny Asset Management | Dec 2023 | 20k | $203k |
| Goldman Sachs Group | Dec 2023 | 18k | $182k |
| Springbok Capital Management | Sep 2023 | 16k | $47k |
| Jpmorgan Chase & Co | Dec 2023 | 14k | $141k |
| Virtu Financial | Dec 2023 | 11k | $109k |